Robust IPO activity in 2026, with 254 U.S. deals priced year-to-date through mid-October and $146 billion raised in the first three quarters, reflects strong investor demand for AI-adjacent and growth companies amid resilient equity markets. Higher Treasury yields near 5.3% have compressed valuations and softened the Nasdaq IPO Pulse recently, yet follow-on offerings and select debuts continue as firms file S-1s and price transactions, including upcoming biotech and infrastructure names. Goldman Sachs projects $175 billion in 2027 IPO proceeds following a potential record $675 billion total equity issuance this year. Key near-term catalysts include Anthropic’s targeted November listing and ongoing pipeline conversions before year-end, with trader sentiment anchored in the demonstrated capacity of public markets to absorb large supply despite elevated rates.